Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-111602
Filing Date
2025-11-13
Accepted
2025-11-13 19:39:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 14096
  Complete submission text file 0001104659-25-111602.txt   15951
Mailing Address 5956 SHERRY LANE SUITE 1365 DALLAS TX 75225
Business Address 5956 SHERRY LANE SUITE 1365 DALLAS TX 75225 214-468-0008
Prosight Management, LP (Filed by) CIK: 0001617201 (see all company filings)

EIN.: 263706721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Subject) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94252 | Film No.: 251480485
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)